Enjoy complimentary customisation on priority with our Enterprise License!
The gastrointestinal bleeding treatment market size is estimated to grow by USD 182.6 million at a CAGR of 4.5% between 2023 and 2028. Colonoscopy, a minimally invasive diagnostic procedure, has gained significant popularity due to the increasing prevalence of gastrointestinal diseases and favorable initiatives from healthcare organizations. This procedure allows for the examination of the entire colon and rectum using a flexible tube with a camera and light. The growing geriatric population, who are more susceptible to colon cancer, further emphasizes the importance of this procedure. Colonoscopies enable early detection and prevention of colon cancer, making it a crucial tool in maintaining gastrointestinal health. With advancements in technology, the procedure is now more comfortable and efficient than ever before. These factors collectively contribute to the increasing demand for colonoscopies in healthcare.
For More Highlights About this Report, Request Free Sample
Gastrointestinal bleeding refers to the loss of blood from the digestive organs, including the esophagus, stomach, small intestine, colon, and other parts of the gastrointestinal tract. This condition can be caused by various factors such as tumors, ulcers, inflammatory bowel disease, diverticulosis, gastritis, and peptic ulcers. The treatment for gastrointestinal bleeding varies depending on the cause and severity of the condition. Flexible endoscopy is a common diagnostic tool used to identify the source of bleeding. Treatment procedures include endoscopic hemostasis, surgery, and medication. Healthcare facilities and workers play a crucial role in the diagnosis and treatment of gastrointestinal bleeding. The geriatric population is at a higher risk of developing gastrointestinal bleeding due to age-related factors and chronic diseases such as gastric cancers, diverticulosis, and peptic ulcers. Comorbidities and anticoagulant prescriptions also increase the risk of gastrointestinal bleeding. The gastrointestinal bleeding treatment market is expected to grow due to the increasing prevalence of gastrointestinal disorders and the aging population. The market is driven by the development of new treatment programs and advancements in diagnosis and treatment procedures. The market is segmented based on the type of gastrointestinal bleeding, diagnosis, treatment, and end-users. The market for endoscopic hemostasis is expected to grow significantly due to its effectiveness in controlling bleeding during diagnostic and therapeutic endoscopic procedures. The market for cancer screening is also expected to grow due to the increasing incidence of gastrointestinal cancers. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The favorable initiatives and increasing prevalence of gastrointestinal diseases is notably driving market growth. The global market for gastrointestinal bleeding treatment is experiencing significant growth due to the rising prevalence of gastrointestinal disorders in the stomach, small intestine, and colon. Acute and chronic cases of gastrointestinal diseases, including diverticulosis, gastritis, peptic ulcers, inflammatory bowel disease, and others, are contributing to the market's expansion. An aging population and the presence of comorbidities are also fueling the demand for advanced medical technology and diagnostic techniques. Gastrointestinal anatomy and healthcare spending are key factors influencing the market's growth. The increasing use of capsule endoscopy, sophisticated imaging, and screening programs for early detection and diagnosis are transforming the gastrointestinal bleeding treatment landscape. Anticoagulant prescriptions and lifestyle factors such as smoking and binge drinking are also driving market growth. Regulatory support for innovative treatments and a focus on patient safety are further propelling market expansion. Overall, the gastrointestinal bleeding treatment market is expected to continue growing as medical advancements and increased awareness lead to improved patient outcomes. Thus, such factors are driving the growth of the market during the market forecast period.
Funding for GI research studies and endoscopic devices is the key trend in the market. The gastrointestinal bleeding treatment market encompasses interventions for addressing bleeding in the stomach, small intestine, and colon. Acute and chronic cases of gastrointestinal disorders, such as diverticulosis, gastritis, peptic ulcers, and inflammatory bowel disease, can lead to gastrointestinal bleeding. With an aging population and an increase in comorbidities, the prevalence of these conditions is on the rise. Anticoagulant prescriptions and lifestyle factors like smoking and binge drinking further contribute to the incidence of gastrointestinal bleeding. Medical technology advancements, including capsule endoscopy and sophisticated imaging, have significantly improved diagnostic techniques for gastrointestinal bleeding. Screening programs and healthcare spending are essential for early detection and effective treatment. Regulatory support and patient safety are crucial considerations in the development of innovative treatments. The gastrointestinal anatomy's complexities necessitate continuous research and investment to provide better patient outcomes. Thus, such trends will shape the growth of the market during the forecast period.
The high treatment costs are the major challenge that affects the growth of the market. The global market encompasses the diagnosis and management of bleeding conditions in the stomach, small intestine, and colon. Acute and chronic cases of gastrointestinal disorders, including diverticulosis, gastritis, peptic ulcers, and inflammatory bowel disease, can lead to GI bleeding. An aging population and increasing prevalence of comorbidities, such as anticoagulant prescriptions, contribute to the market growth. However, the high costs of medical technology, such as capsule endoscopy and sophisticated imaging, and screening programs, limit market expansion, particularly in developing and emerging economies. Diagnostic techniques, healthcare spending, and lifestyle factors, such as smoking and binge drinking, also impact the market dynamics. Regulatory support and innovative treatment options offer opportunities for growth, while patient safety remains a top priority. Endoscopic kits, a significant component of GI bleeding treatment, are expensive and require extensive procurement procedures and budget considerations, making them a financial burden for end-users. Equipment maintenance further adds to the financial strain. Hence, the above factors will impede the growth of the market during the forecast period.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Boston Scientific Corp. - The company offers gastrointestinal bleeding treatment that includes polypectomy, retrieval devices band ligator, clips, endoluminal surgery devices, enteral access and feeding tubes, fiducial markers, forceps, and guidewires.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The endoscopic mechanical devices segment is estimated to witness significant growth during the forecast period. Gastrointestinal bleeding is a significant health concern affecting the digestive organs in both the upper and lower tracts. Medicine plays a crucial role in diagnosing and treating this condition through various procedures, including flexible endoscopy. This minimally invasive technique enables healthcare workers to examine the GI tract for tumors, ulcers, and other causes of bleeding.
Get a glance at the market share of various regions Download the PDF Sample
The endoscopic mechanical devices segment accounted for USD 325 million in 2018. Flexible endoscopy is essential for cancer screening and surveillance in the geriatric population, particularly for gastric cancers and colorectal cancers such as colon, rectal, and esophageal. Treatment programs in healthcare facilities employ skilled labor and advanced technology, including endoscopic hemostasis, to manage bleeding and prevent complications. Fujifilm Healthcare, Ambu, aScope Gastro, and aBox 2 are some companies providing innovative solutions for gastrointestinal bleeding diagnosis and treatment. AI technology is also being integrated into clinical trials to improve the accuracy of diagnosis and treatment procedures. Prevention measures include addressing chronic diseases like pylori infection and peptic ulcers.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
Gastrointestinal bleeding, a potentially life-threatening condition, affects the digestive organs and can be caused by various factors including cancer, tumors, chronic diseases, ulcers, and pylori infection. Medicine plays a crucial role in the diagnosis, treatment, and prevention of gastrointestinal bleeding. Flexible endoscopy, a diagnostic procedure, enables healthcare workers to examine the GI tract division, including the upper and lower GI tract, and perform endoscopic hemostasis for bleeding control. Fujifilm Healthcare, Ambu, and aScope Gastro are among the healthcare facilities and companies providing advanced solutions for gastrointestinal bleeding treatment. Skilled labor, such as gastroenterologists, plays a significant role in the implementation of treatment programs for this condition. Early cancer screening and surveillance are essential for the geriatric population, who are at a higher risk of developing gastric cancers, colon cancer, rectal cancer, and colorectal cancer. AI and clinical trials are also being explored for the early detection and treatment of digestive tract diseases, including esophagus conditions and colorectal polyps. The OECD and Cancer Society advocate for the importance of regular check-ups and awareness campaigns to promote health and prevent gastrointestinal bleeding.
The market report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Million " for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The market is witnessing significant growth due to the increasing prevalence of digestive diseases such as gastric cancers, tumors, ulcers, and chronic diseases. The market is primarily driven by the need for accurate diagnosis and effective treatment procedures for GI bleeding. Flexible endoscopy plays a crucial role in the diagnosis and treatment of GI bleeding. Healthcare facilities and skilled labor are essential for the successful implementation of endoscopic hemostasis procedures. The geriatric population is a significant consumer of GI bleeding treatment due to the higher prevalence of chronic diseases and digestive tract disorders in this age group. Major players in the market include Fujifilm Healthcare, Ambu, and Fujifilm's GI tract division. The market is segmented into Upper GI Tract and Lower GI Tract. Peptic ulcers caused by Helicobacter pylori infection and gastroenterologists are key focus areas for the market. Prevention is a critical aspect of the GI bleeding treatment market, with cancer screening and surveillance programs playing a significant role. The OECD, Cancer Society, and other health organizations emphasize the importance of regular colon cancer, rectal cancer, and colorectal cancer screenings. Artificial Intelligence (AI) is also being explored for the early detection of colorectal polyps and clinical trials are underway to assess its effectiveness. The market is expected to grow further with the development of advanced diagnostic and treatment technologies, increasing healthcare spending, and rising awareness about digestive health.
Market Scope |
|
Report Coverage |
Details |
Page number |
134 |
Base year |
2023 |
Historic period |
2018 - 2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.5% |
Market growth 2024-2028 |
USD 182.6 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
4.23 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 43% |
Key countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Boston Scientific Corp., Conmed Corp., Cook Group Inc., EndoClot Plus Inc., Erbe Elektromedizin GmbH, Mayo Foundation for Medical Education and Research, Medtronic Plc, Olympus Corp., Ovesco Endoscopy AG, STERIS plc, and University Hospitals |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.